About this trial
The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.
Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged 60 years and older
high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
receives reperfusion intervention.
Disqualifiers
Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
Incomplete medical records.
Trial population
All patients aged 60 years and older were diagnosed with non-ST elevation acute coronary syndrome. Diagnosed with high-risk acute non-ST elevation syndrome and treated at Gia Dinh People's Hospital, Thong Nhat Hospital during the study period.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
In-hospital death
recorded when death occurs during treatment or is confirmed by in-hospital monitoring
Secondary outcomes
after 12 months death
determined by the patient follow-up period from hospital discharge until results were recorded
MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure
recorded
Sponsors and contacts
Click on the lead sponsor to view all of their trials.